The four main clinicopathological subsets of melanoma are described and the
arguments for their retention in a research setting presented. Further add
itional subsets are described, including partly regressed primary melanoma,
melanoma arising in a congenital naevus and multiple primary tumours.
Pathological prognostic indicators are discussed and the pre-eminent signif
icance of tumour thickness and its interaction with ulceration described. T
he need for accurate personal predictive profiles as distinct from those re
levant to populations is discussed, as is the need for a molecular marker o
f metastatic potential.